These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
767 related items for PubMed ID: 27167638
1. Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study. Hayes JF, Pitman A, Marston L, Walters K, Geddes JR, King M, Osborn DP. JAMA Psychiatry; 2016 Jun 01; 73(6):630-7. PubMed ID: 27167638 [Abstract] [Full Text] [Related]
2. Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study. Hayes JF, Marston L, Walters K, Geddes JR, King M, Osborn DP. PLoS Med; 2016 Aug 01; 13(8):e1002058. PubMed ID: 27483368 [Abstract] [Full Text] [Related]
3. Mortality risk and mood stabilizers in bipolar disorder: a propensity-score-weighted population-based cohort study in 2002-2018. Chan JKN, Wong CSM, Fang CZ, Hung SC, Lo HKY, Chang WC. Epidemiol Psychiatr Sci; 2024 May 23; 33():e31. PubMed ID: 38779809 [Abstract] [Full Text] [Related]
4. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations. Wingård L, Bodén R, Brandt L, Tiihonen J, Tanskanen A, Kieler H, Andersen M, Reutfors J. J Affect Disord; 2017 Aug 01; 217():16-23. PubMed ID: 28364619 [Abstract] [Full Text] [Related]
6. Suicidal Behavior During Lithium and Valproate Treatment: A Within-Individual 8-Year Prospective Study of 50,000 Patients With Bipolar Disorder. Song J, Sjölander A, Joas E, Bergen SE, Runeson B, Larsson H, Landén M, Lichtenstein P. Am J Psychiatry; 2017 Aug 01; 174(8):795-802. PubMed ID: 28595491 [Abstract] [Full Text] [Related]
10. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R. Health Technol Assess; 2004 May 01; 8(19):iii-iv, 1-187. PubMed ID: 15147609 [Abstract] [Full Text] [Related]
11. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder. Woodward TC, Tafesse E, Quon P, Lazarus A. Pharmacoeconomics; 2010 May 01; 28(9):751-64. PubMed ID: 20623994 [Abstract] [Full Text] [Related]
13. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine. Yerevanian BI, Koek RJ, Mintz J. J Affect Disord; 2007 Nov 01; 103(1-3):5-11. PubMed ID: 17628692 [Abstract] [Full Text] [Related]
14. Olanzapine in long-term treatment for bipolar disorder. Cipriani A, Rendell JM, Geddes J. Cochrane Database Syst Rev; 2009 Jan 21; (1):CD004367. PubMed ID: 19160237 [Abstract] [Full Text] [Related]
15. Association of Lithium Treatment With the Risk of Osteoporosis in Patients With Bipolar Disorder. Köhler-Forsberg O, Rohde C, Nierenberg AA, Østergaard SD. JAMA Psychiatry; 2022 May 01; 79(5):454-463. PubMed ID: 35353126 [Abstract] [Full Text] [Related]
16. Bipolar pharmacotherapy and suicidal behavior Part 3: impact of antipsychotics. Yerevanian BI, Koek RJ, Mintz J. J Affect Disord; 2007 Nov 01; 103(1-3):23-8. PubMed ID: 17604119 [Abstract] [Full Text] [Related]